Evolving progress in oncologic and operative outcomes for esophageal and junctional cancer: Lessons from the experience of a high-volume center

Journal of Thoracic and Cardiovascular Surgery

Volumn 143, Issue 5, 2012, Pages

  Reynolds, John V ^a   Donohoe, Claire L ^a   McGillycuddy, Erin ^a   Ravi, Naraymasamy ^a   O'Toole, Dermot ^a   O'Byrne, Ken ^a   Hollywood, Donal ^a  

^a ST JAMES S HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CANCER MORTALITY; CANCER SPECIFIC SURVIVAL; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CANCER THERAPY; DISEASE SPECIFIC SURVIVAL; EARLY CANCER; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; FEMALE; HUMAN; LOWER ESOPHAGUS SPHINCTER; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SMALL CELL CARCINOMA; SURGICAL MORTALITY; TREATMENT OUTCOME; TUMOR REGRESSION;

EID: 84859746600     PISSN: 00225223     EISSN: 1097685X     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2011.12.003     Document Type: Article

References (25)

1. Enzinger PC, Mayer RJ. Esophageal cancer. N Engl J Med. 2003;349:2241-52. (Pubitemid 37485141)
2. Portale G, Hagen JA, Peters JH, Chan LS, De Meester S, Gandamiharda TAK, et al. Modern 5-year survival of resectable esophageal adenocarcinoma: single institution experience with 263 patients. J Am Coll Surg. 2006;202:588-96.
3. Altorki N, Kent M, Ferrara C, Port J. Three-field lymph node dissection for squamous cell and adenocarcinoma of the esophagus. Ann Surg. 2002;236:177-83. (Pubitemid 34809536)
4. Low DE, Kunz S, Schembre D, Otero H, Malpass T, Hsi A, et al. Esophagectomy-it's not just about mortality anymore: standardized perioperative clinical pathways improve outcomes. J Gastrointest Surg. 2007;11:1395-402.
5. Courrech Staal EFW, Wouters MWJM, Boot H, Tollenaar RAEM, van Sandick JW. Quality of care indicators for oesophageal cancer surgery: a review. Eur J Surg Oncol. 2010;36:1035-43.
6. Reynolds JV, Muldoon C, Hollywood D, Ravi N, Rowley S, O'Byrne K, et al. Long-term outcomes following neoadjuvant chemoradiotherapy for esophageal cancer. Ann Surg. 2007;245:707-16. (Pubitemid 46684100)
7. Gebski V, Burmeister B, Smithers BM, Foo K, Zalcberg J, Simes J, et al. Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis. Lancet Oncol. 2007;8:226-34. (Pubitemid 46291702)
8. Birkmeyer JD, Siewers AE, Finlayson EV, Stukel TA, Lucas L, Batista I, et al. Hospital volume and surgical mortality in the United Stares. N Engl J Med. 2002;346:1128-37. (Pubitemid 34984604)
9. Siewert JR, Feith M, Werner M, Stein HJ. Adenocarcinoma of the esophagogastric junction: results of surgical therapy based on anatomical/topographical classification in 1002 consecutive patients. Ann Surg. 2000;232:353-61.
10. Macdonald JS, Smalley SR, Benedetti J, Hundahl SA, Estes NC, Stemmermann GN, et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of stomach or gastroesophageal junction. N Engl J Med. 2001;345:725-30.
11. Cunningham D, Allum W, Stenning SP, Thompson JN, Van de Velde CJH, Nicolson M, et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med. 2006;355:11-20.
12. Lerut T, Decker G, CoosemansW, de Leyn P, Decaluwe H, Nafteux P, et al. Quality indicators of surgery for adenocarcinoma of the esophagus and gastroesophageal junction. Recent Results Cancer Res. 2010;182:127-42.
13. Reynolds JV, Ravi N, Hollywood D, Kennedy J, Rowley S, Ryan A, et al. Neoadjuvant chemoradiation may increase the risk of respiratory complications and sepsis after transthoracic esophagectomy. J Thoracic Cardiovasc Surg. 2006; 132:549-55.
14. Ibrahim NB. Guidelines for handling oesophageal resection biopsies and resection specimens and their reporting. J Clin Pathol. 2000;53:89-94. (Pubitemid 30075049)
15. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A, eds. AJCC cancer staging manual. 7th ed. New York, NY: Springer; 2010.
16. Mandard AM, Dalibard F, Mandard JC, Marnay J, Henry-Amar M, Petiot JF, et al. Pathologic assessment of tumor regression after preoperative chemoradiotherapy for esophageal carcinoma. Cancer. 1994;73:2680-6. (Pubitemid 24166250)
17. Lagarde SM, Vrouenraets BC, Stassen LP, can Lanschot JJ. Evidence-based surgical treatment of esophageal cancer; overview of high quality studies. Ann Thorac Surg. 2010;89:1319-26.
18. Orringer MB, Marshall B, Chang AC, Lee J, Pickens A, Lau CL. Two thousand transhiatal esophagectomies. Ann Surg. 2007;246:363-74.
19. Wouters MW, Karim-Kos HE, Le Cessie S, Wijnhoven BPL, Stassen LPS, Steup WH, et al. Centralization of esophageal cancer surgery: does it improve clinical outcome? Ann Surg Oncol. 2009;16:1789-98.
20. Law S, Kwong DL, Kwok KF,Wong KH, Chu KM, Sham JS, et al. Improvement in treatment results and long term survival in patients with esophageal cancer: impact of chemoradiation and change in treatment strategy. Ann Surg. 2003; 238:339-47.
21. Ruol A, Castoro C, Portale G, Cavallin MS, Sileni VC, Cagol M, et al. Trends in management and prognosis for esophageal cancer surgery. Arch Surg. 2009;144: 247-54.
22. Salahudeen HM, Balan A, Naik K, Mirsadree S, Scarsbrook AF. Impact of the introduction of integrated PET-CT into the preoperative staging pathway of patients with potentially operable oesophageal carcinoma. Clin Radiol. 2008;63:765-73.
23. Bedenne L, Michel P, Bouche O, Milan C, Mariette C, Conroy T, et al. Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102. J Clin Oncol. 2007;25:1160-8. (Pubitemid 46640561)
24. Porter ME. Value-based health care delivery. Ann Surg. 2008;248:503-9.
25. American College of Surgeons. National Surgical Improvement Programme. Available at: http://www.acsnsqip.org/. Accessed April 8, 2011.